Key Market Indicator:
F&G: 24
25.838,90 NASDAQ · 47.579,00 DOW · 6.876,60 S&P · 3.937,61 Gold · 64,70 BRENT

One Community. One Spirit. N#1 Broker.
all asset classes · all possibilities

Switch View
Hedge the Peak | Protect your Profits
© BusinessWire
05.11.2025
ISIN: US88023B1035
Tempus AI, Inc.
TEM
LISTED
NASDAQ
Tempus Announces Six Abstracts Accepted for Presentation at the Society for Immunotherapy of Cancer Annual Meeting 2025
Article
News Preview
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced that six abstracts have been accepted for presentation at the Society for Immunotherapy of Cancer (SITC) Annual Meeting 2025. The meeting is taking place November 5 - 9 at the Gaylord National Convention Center in National...
Themefolio
Profiler
Peergroup
© BusinessWire
05.11.2025
ISIN: US40412C1018
HCA Healthcare Inc
HCA
LISTED
NYSE
HCA Healthcare Announces $1.5 Million HCA Healthcare Foundation Grant to Support March of Dimes' Low Dose, Big Benefits™ Campaign
Article
News Preview
HCA Healthcare, Inc. (NYSE:HCA), one of the nation’s leading healthcare providers, today announced the HCA Healthcare Foundation, through its Healthier Tomorrow Fund, will strengthen its collaboration with March of Dimes, a leading nonprofit fighting for the health of all moms and babies, through a new $1.5 million grant to support their Low Dose,...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: US69404D1081
Pacific Biosciences of California Inc
PACB
LISTED
NASDAQ
HiFi Solves Consortium Publishes First Major Study Demonstrating the Clinical Research Power of PacBio HiFi Genomes
Article
News Preview
New multi-center study identifies 100% of clinically relevant variants in the study, including those not detected by short-read sequencing technologies, positioning HiFi as the bridge between research and clinical-grade genomics New multi-center study identifies 100% of clinically relevant variants in the study, including those not detected by shor...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
More Info
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© Globe Newswire
05.11.2025
ISIN: US5898891040
Merit Medical Systems Inc
MMSI
LISTED
NASDAQ
Merit Medical Releases 24-Month Efficacy Results from the Randomized Arteriovenous Fistula (AVF) Arm of the WRAPSODY Arteriovenous Access Efficacy (WAVE) Trial
Article
News Preview
SOUTH JORDAN, Utah, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced positive findings from the randomized AVF arm of the WAVE trial. These findings were presented during the Late-Breaking Clinical Trials session on Tuesday, November 4, 2025, at the Vascular In...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© BusinessWire
05.11.2025
ISIN: VGG312491084
Establishment Labs Holdings Inc
ESTA
LISTED
NASDAQ
Establishment Labs Reports Third Quarter 2025 Financial Results
Article
News Preview
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced financial results for the third quarter ended September 30, 2025. Third Quarter Highlights and Outlook (Unaudited) Third quarter worldwide r...
Themefolio
Profiler
Peergroup
© Newsfile
05.11.2025
ISIN: CA14161Y2006
Cardiol Therapeutics Inc
CRDL
LISTED
TSX
Cardiol Therapeutics' Phase II ARCHER Trial Results to be Presented at the European Society of Cardiology Scientific Meeting on Myocardial & Pericardial Diseases
Article
News Preview
The ESC M&PD meeting brings together the world's experts working to improve the treatment of myocarditis and pericarditis.Presentation to provide comprehensive findings from the ARCHER trial following the reporting of topline results demonstrating a notable improvement in extracellular volume and a significant reduction in left ventricular mass...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: CA45074T1021
Ianthus Capital Holdings Inc.
IAN
LISTED
CSE
iAnthus Continues Expansion in Florida with GrowHealthy Dispensary Opening in Fort Myers
Article
News Preview
iAnthus Continues Expansion in Florida with GrowHealthy Dispensary Opening in Fort Myers...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: US59503A2042
Microbot Medical Inc.
MBOT
LISTED
NASDAQ
Microbot Medical® Commences the Limited Market Release of its LIBERTY® Endovascular Robotic System in the U.S. 
Article
News Preview
Microbot Medical® Commences the Limited Market Release of its LIBERTY® Endovascular Robotic System in the U.S....
Themefolio
Profiler
Peergroup
© BusinessWire
05.11.2025
ISIN: US45780L1044
Inogen Inc
INGN
LISTED
NASDAQ
Inogen Announces Third Quarter 2025 Financial Results
Article
News Preview
Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the quarter ended September 30, 2025. Recent Highlights $92.4 million revenue, a year-over-year increase of 4.0%, marking the seventh consecutive quarter of mid-single-digit pe...
Themefolio
Profiler
Peergroup
© BusinessWire
05.11.2025
ISIN: US1404752032
Sonida Senior Living Inc
SNDA
LISTED
NYSE
Sonida Senior Living Announces Strategic Merger with CNL Healthcare Properties, Inc. in a Stock and Cash Transaction Valued at Approximately $1.8 Billion, Creating $3 Billion Pure-Play Senior Housing Owner-Operator
Article
News Preview
Sonida Senior Living, Inc. (“Sonida” or the “Company”) (NYSE: SNDA), a leading owner, operator and investor in senior living communities, and CNL Healthcare Properties, Inc. (“CHP”), a public non-traded real estate investment trust (“REIT”) which owns a national portfolio of high-quality senior housing communities, today announced a definitive mer...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: US57777K1060
MaxCyte Inc
MXCT
LISTED
NASDAQ
MaxCyte Reports Preliminary Third Quarter 2025 Financial Results and Reiterates Full Year 2025 Revenue Guidance
Article
News Preview
MaxCyte will now host its earnings conference call on November 12, 2025...
Themefolio
Profiler
Peergroup
© BusinessWire
05.11.2025
ISIN: US92790C1045
Viridian Therapeutics Inc
VRDN
LISTED
NASDAQ
Viridian Therapeutics Reports Third Quarter 2025 Financial Results and Highlights Recent Progress
Article
News Preview
Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing, and commercializing potentially best-in-class medicines for serious and rare diseases, today reported recent business highlights and financial results for the third quarter ended September 30, 2025. “The Viridian team continues to deliver stron...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© BusinessWire
05.11.2025
ISIN: CA60255C8850
Mind Medicine (MindMed) Inc
MNMD
LISTED
NASDAQ
MindMed to Participate in Upcoming Investor Conferences
Article
News Preview
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that members of the Company’s management team will participate in the following investor conferences: Stifel 2025 Healthcare Conference Fo...
Themefolio
Profiler
Peergroup
© BusinessWire
05.11.2025
ISIN: US1598641074
Charles River Laboratories International Inc
CRL
LISTED
NYSE
Charles River Laboratories Provides Update on Strategic Review
Article
News Preview
Charles River Laboratories International, Inc. (NYSE: CRL) today announced an update on its Board of Directors’ comprehensive strategic review of the Company’s business and growth prospects. The Board strongly supports the Company’s strategic direction and believes it should continue to focus on strengthening its leading scientific portfolio withi...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: US56400P2011
MannKind Corporation
MNKD
LISTED
NASDAQ
MannKind Corporation Reports Third Quarter 2025 Financial Results and Provides Business Update
Article
News Preview
MANNKIND CORPORATION REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: US52635N1037
LENZ Therapeutics Inc
LENZ
LISTED
NASDAQ
LENZ Therapeutics Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
Article
News Preview
VIZZTM (aceclidine ophthalmic solution) 1.44% received FDA approval for the treatment of presbyopia...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: US74006W1080
Praxis Precision Medicines Inc
PRAX
LISTED
NASDAQ
Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2025 Financial Results
Article
News Preview
Announced positive results from two pivotal Phase 3 Essential3 studies of ulixacaltamide HCl in essential tremor (ET); Pre-NDA meeting with FDA scheduled for Q4 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: NL00150012L7
NewAmsterdam Pharma Company N.V.
NAMS
LISTED
NASDAQ
NewAmsterdam Pharma Provides Corporate Update and Reports Third Quarter Financial Results
Article
News Preview
– Marketing Authorization Applications for obicetrapib and FDC of obicetrapib plus ezetimibe accepted for review by European Medicines Agency –...
Themefolio
Profiler
Peergroup
© BusinessWire
05.11.2025
ISIN: US4834971032
Kalvista Pharmaceuticals Inc
KALV
LISTED
NASDAQ
KalVista Pharmaceuticals to Present at Upcoming Investor Conferences
Article
News Preview
KalVista Pharmaceuticals, Inc. (Nasdaq: KALV), today announced that the Company will participate in a fireside chat at each of the following upcoming investor conferences: Stifel 2025 Healthcare Conference on Wednesday, November 12, 2025, at 8:40 a.m. EST Jefferies Global Healthcare Conference in London on Wednesday, November 19, 2025, at 1:...
Themefolio
Profiler
Peergroup
© BusinessWire
05.11.2025
ISIN: US1598641074
Charles River Laboratories International Inc
CRL
LISTED
NYSE
Charles River Laboratories Announces Third-Quarter 2025 Results
Article
News Preview
Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the third quarter of 2025. For the quarter, revenue was $1.00 billion, a decrease of 0.5% from $1.01 billion in the third quarter of 2024. The impact of foreign currency translation increased reported revenue by 1.3%, and the divestiture of a small Safety As...
Themefolio
Profiler
Peergroup
© BusinessWire
05.11.2025
ISIN: US3741631036
Geron Corp
GERN
LISTED
NASDAQ
Geron Corporation Reports Third Quarter 2025 Financial Results and Recent Business Highlights
Article
News Preview
Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today reported financial results for the third quarter of 2025 and recent business highlights. "The high unmet need in lower-risk MDS is well known, and RYTELO is a therapy with a novel mechanism of action...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: US52886X1072
Lexeo Therapeutics Inc
LXEO
LISTED
NASDAQ
Lexeo Therapeutics Reports Third Quarter 2025 Financial Results and Operational Highlights
Article
News Preview
Lexeo Therapeutics Reports Third Quarter 2025 Financial Results and Operational Highlights...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: US57055L1070
Marker Therapeutics, Inc.
MRKR
LISTED
NASDAQ
Marker Therapeutics appoints Kathryn Penkus Corzo to Board of Directors
Article
News Preview
HOUSTON, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage immuno-oncology company focusing on developing next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications, today announced the appointment of Kathryn Penkus Corzo, R.Ph., MBA to the Co...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: US76200L3096
Rezolute, Inc.
RZLT
LISTED
NASDAQ
Rezolute to Host Virtual Investor Event on Ersodetug Development Program
Article
News Preview
Webcast scheduled for Monday, November 10 at 12:00 pm EST Webcast scheduled for Monday, November 10 at 12:00 pm EST...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: KYG2545C1042
Crescent Biopharma, Inc.
CBIO
LISTED
NASDAQ
Crescent Biopharma to Present at November Investor Conferences
Article
News Preview
WALTHAM, Mass., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today announced that management is scheduled to present at the following investor conferences in November:...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: US02155H1014
Altimmune, Inc.
ALT
LISTED
NASDAQ
Altimmune to Participate in Two Upcoming Investor Conferences
Article
News Preview
GAITHERSBURG, Md., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and cardiometabolic diseases, today announced that members of the Company’s management team will participate and be available for one-on-one meetings at the follo...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: US20454B1044
Compass Therapeutics Inc.
CMPX
LISTED
NASDAQ
Compass Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Article
News Preview
BOSTON, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics, today reported third quarter 2025 financial results and provided a business update....
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: IL0011316309
Mediwound Ltd
MDWD
LISTED
NASDAQ
MediWound to Report Third Quarter 2025 Financial Results
Article
News Preview
MediWound to Report Third Quarter 2025 Financial Results...
Themefolio
Profiler
Peergroup
© BusinessWire
05.11.2025
ISIN: US03073E1055
Cencora Inc
COR
LISTED
NYSE
Cencora Reports Fiscal 2025 Fourth Quarter and Fiscal Year End Results
Article
News Preview
Cencora, Inc. (NYSE: COR) today reported that in its fiscal year 2025 fourth quarter ended September 30, 2025, revenue increased 5.9 percent to $83.7 billion. Revenue increased 9.3 percent to $321.3 billion for fiscal year 2025. On the basis of U.S. generally accepted accounting principles (GAAP), diluted earnings per share (EPS) was $(1.75) for t...
Themefolio
Profiler
Peergroup
© BusinessWire
05.11.2025
ISIN: CA22587M1068
Cresco Labs Inc
CL
LISTED
CSE
Cresco Labs Delivers Strong Q3, Maintains Market Leadership, and Unlocks New Growth Opportunities
Article
News Preview
Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today released its financial and operating results for the third quarter ended September 30, 2025. All financial inform...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: US92337R1014
Vera Therapeutics Inc
VERA
LISTED
NASDAQ
Vera Therapeutics Provides Business Update and Reports Third Quarter 2025 Financial Results
Article
News Preview
Vera Therapeutics today reported its business highlights and financial results for the third quarter ended September 30, 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: KY61559X1045
MoonLake Immunotherapeutics
MLTX
LISTED
NASDAQ
MoonLake Immunotherapeutics Announces Pricing of $75 Million Underwritten Offering
Article
News Preview
ZUG, Switzerland, November 5, 2025 – MoonLake Immunotherapeutics (Nasdaq: MLTX) (“MoonLake”), a clinical-stage biotechnology company focused on advancing therapies to address significant unmet needs in inflammatory skin and joint diseases, today announced the pricing of an underwritten offering of 7,142,857 Class A ordinary shares at an offering pr...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: US83086J2006
Skye Bioscience Inc
SKYE
LISTED
NASDAQ
Skye Bioscience Late-Breaking Oral Abstract at ObesityWeek 2025 to Highlight Improvement in Rebound Weight Gain
Article
News Preview
During 12-week post-treatment period, nimacimab plus semaglutide blunts weight regain compared to semaglutide alone in subset analysis During 12-week post-treatment period, nimacimab plus semaglutide blunts weight regain compared to semaglutide alone in subset analysis...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: US0352551081
Anika Therapeutics Inc
ANIK
LISTED
NASDAQ
Anika Reports Third Quarter 2025 Financial Results
Article
News Preview
Commercial Channel revenue up 22% with continued strong Integrity™ Implant System and Hyalofast® growth, and double-digit International OA Pain Management growth...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: US15102K1007
Celcuity Inc
CELC
LISTED
NASDAQ
Celcuity Inc. Schedules Release of Third Quarter 2025 Financial Results and Webcast/Conference Call
Article
News Preview
MINNEAPOLIS, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that it will release its financial results for the third quarter 2025 after the market closes on Wednesday, November 12, 2025. Management will host a webcast/t...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: US47973J1025
Joint Corp
JYNT
LISTED
NASDAQ
The Joint Corp. Board of Directors Authorizes an Additional $12 Million for Stock Repurchase Program
Article
News Preview
SCOTTSDALE, Ariz., Nov. 05, 2025 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic® network, announced that its board of directors has authorized an additional $12 million for its stock repurchase program....
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: US09058V1035
BioCryst Pharmaceuticals Inc
BCRX
LISTED
NASDAQ
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Article
News Preview
RESEARCH TRIANGLE PARK, N.C., Nov. 05, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst’s board of directors granted three newly-hired employees restricted stock units (RSUs) covering an aggregate of 30,700 shares of BioCryst common stock. The RSUs were granted as o...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: US04335A1051
Arvinas, Inc.
ARVN
LISTED
NASDAQ
Arvinas Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Article
News Preview
– Presented positive data from Phase 1 clinical trials with ARV-102 in healthy volunteers and patients with Parkinson’s disease –...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: GB00BMVP7Y09
Royalty Pharma PLC
RPRX
LISTED
NASDAQ
Royalty Pharma Reports Third Quarter 2025 Results
Article
News Preview
NEW YORK, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today reported financial results for the third quarter of 2025 and raised full year 2025 guidance for Portfolio Receipts....
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: US10170A1007
Boundless Bio, Inc.
BOLD
LISTED
NASDAQ
Boundless Bio Reports Third Quarter 2025 Financial Results and Business Highlights
Article
News Preview
 Enrollment ongoing in BBI-355 / BBI-825 combination arm of the POTENTIATE trial...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: US3441741077
Foghorn Therapeutics Inc
FHTX
LISTED
NASDAQ
Foghorn Therapeutics Provides Third Quarter 2025 Financial and Corporate Update
Article
News Preview
Ongoing FHD-909 (LY4050784) Phase 1 dose escalation trial in SMARCA4 (BRG1)-mutated cancer remains on track with non-small cell lung cancer (NSCLC) as the primary target population ...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: US5171251003
Larimar Therapeutics Inc
LRMR
LISTED
NASDAQ
Larimar Therapeutics Reports Third Quarter 2025 Financial Results
Article
News Preview
BALA CYNWYD, Pa., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (Larimar) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today reported its third quarter 2025 operating and financial results....
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: US8294011080
Sionna Therapeutics Inc
SION
LISTED
NASDAQ
Sionna Therapeutics Reports Third Quarter 2025 Financial Results
Article
News Preview
Initiated PreciSION CF Phase 2a proof-of-concept trial evaluating NBD1 stabilizer SION-719 as an add-on to standard of care in participants with cystic fibrosis...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: US91678A1079
Upstream Bio, Inc.
UPB
LISTED
NASDAQ
Upstream Bio Reports Third Quarter 2025 Financial Results and Highlights Continued Progress
Article
News Preview
– Positive top-line results from VIBRANT Phase 2 trial of verekitug in CRSwNP reported in September showed statistically significant and clinically meaningful effects on primary and key secondary endpoints when administered once every 12 weeks –...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: KY61559X1045
MoonLake Immunotherapeutics
MLTX
LISTED
NASDAQ
MoonLake Immunotherapeutics Reports Third Quarter 2025 Financial Results and Announces New Data from Clinical Trials of its Nanobody® Sonelokimab
Article
News Preview
ZUG, Switzerland, November 5, 2025 – MoonLake Immunotherapeutics (NASDAQ: MLTX) (“MoonLake” or the “Company”), a clinical-stage biotechnology company focused on creating next-level therapies for inflammatory diseases, today announced its financial results for the third quarter of 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: US30233G2093
EyePoint Pharmaceuticals Inc
EYPT
LISTED
NASDAQ
EyePoint Reports Third Quarter 2025 Financial Results and Highlights Recent Corporate Developments
Article
News Preview
– Phase 3 LUGANO and LUCIA clinical trials for DURAVYU™ in wet AMD fully enrolled and on track for data readout beginning in mid-2026 –...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: IL0006290147
Teva Pharmaceutical Industries Ltd
TEVA
LISTED
TLV
Teva's Innovative Portfolio Drives 11th Consecutive Quarter of Growth in Q3 2025; Increases 2025 Outlook for Austedo® and Non-GAAP EPS
Article
News Preview
For an accessible version of this Press Release, please visit www.tevapharm.com...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: US04683R1068
Atea Pharmaceuticals Inc
AVIR
LISTED
NASDAQ
Atea Pharmaceuticals to Host Third Quarter 2025 Financial Results and Business Update Conference Call on November 12, 2025
Article
News Preview
BOSTON, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today announced that it will host a live conference call and audio webcast on Wednesday, November 12,...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: US03753U1060
Apellis Pharmaceuticals Inc
APLS
LISTED
NASDAQ
Apellis Pharmaceuticals to Present at the Stifel 2025 Healthcare Conference
Article
News Preview
WALTHAM, Mass., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will present at the Stifel 2025 Healthcare Conference on Wednesday, November 12, 2025 at 2:40 p.m. ET....
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: US35168W1036
Fractyl Health Inc
GUTS
LISTED
NASDAQ
Fractyl Health to Report Third Quarter 2025 Financial Results and Provide Business Updates on November 12, 2025
Article
News Preview
BURLINGTON, Mass., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the Company), a metabolic therapeutics company focused on pattern-breaking approaches to treat the root causes of obesity and type 2 diabetes (T2D), today announced it will report financial results for the third quarter 2025 and provide business updates on W...
Themefolio
Profiler
Peergroup
© BusinessWire
05.11.2025
ISIN: US4448591028
Humana Inc
HUM
LISTED
NYSE
Humana Reports Third Quarter 2025 Financial Results; Affirms Full Year 2025 Adjusted EPS Guidance
Article
News Preview
Humana Inc. (NYSE: HUM) today reported consolidated pretax results and diluted earnings per share (EPS) for the quarter ended September 30, 2025 (3Q25) versus the quarter ended September 30, 2024 (3Q24) and for the nine months ended September 30, 2025 (YTD 2025) versus the nine months ended September 30, 2024 (YTD 2024) as noted in the tables belo...
Themefolio
Profiler
Peergroup
© BusinessWire
05.11.2025
ISIN: GB00BYMT0J19
LivaNova PLC
LIVN
LISTED
NASDAQ
LivaNova Reports Third-Quarter 2025 Results; Raises 2025 Guidance
Article
News Preview
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today reported results for the third quarter ended September 30, 2025 and raised full-year 2025 guidance. Financial Summary and Highlights(1) Third-quarter revenue of $357.8 million increased 12.5% on a reported basis, 11.0% on a constant-currency basis, and 12.5% on an o...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: US75629V1044
Recursion Pharmaceuticals Inc
RXRX
LISTED
NASDAQ
Recursion Reports Third Quarter 2025 Financial Results and Provides Business Update
Article
News Preview
SALT LAKE CITY, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX) a leading clinical stage TechBio company decoding biology to radically improve lives, today reported business updates and financial results for its third quarter ended September 30, 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: US67577C1053
Ocugen Inc
OCGN
LISTED
NASDAQ
Ocugen Provides Business Update with Third Quarter 2025 Financial Results
Article
News Preview
Conference Call and Webcast Today at 8:30 a.m. ET Conference Call and Webcast Today at 8:30 a.m. ET...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: US34965KAA51
Fortrea Holdings, Inc.
FTRE
LISTED
NASDAQ
Fortrea Reports Third Quarter 2025 Results
Article
News Preview
For the three months ended September 30, 2025, from continuing operations:...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: US75629V1044
Recursion Pharmaceuticals Inc
RXRX
LISTED
NASDAQ
Recursion Announces CEO Transition Plan to Drive Next Phase of Growth
Article
News Preview
Co-Founder and CEO Chris Gibson to Transition to Chairman of the Board; Najat Khan to be named Chief Executive Officer and President Co-Founder and CEO Chris Gibson to Transition to Chairman of the Board; Najat Khan to be named Chief Executive Officer and President...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: US7504911022
RadNet Inc
RDNT
LISTED
NASDAQ
RadNet Expands Comprehensive Remote Scanning Offering with Acquisition of Alpha RT’s Assets
Article
News Preview
DeepHealth commercializes remote-imaging offering featuring TechLive™ remote scanning and Alpha RT’s MRI staffing services, training and safety software....
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: AU000000IMC7
Immuron Limited
IMC
LISTED
ASX
Immuron IMM-529 IND approved by FDA
Article
News Preview
Key Points...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: US6979471090
Palvella Therapeutics Inc
PVLA
LISTED
NASDAQ
Palvella Therapeutics Announces New QTORIN™ Product Candidate, QTORIN™ Pitavastatin, for the Treatment of Disseminated Superficial Actinic Porokeratosis (DSAP), a Rare, Chronic, and Pre-Cancerous Genetic Skin Disease with No FDA-Approved Therapies
Article
News Preview
DSAP is a premalignant, progressive disease characterized by numerous expanding lesions which significantly impact quality-of-life; no FDA-approved therapies exist for the estimated more than 50,000 diagnosed U.S. patients...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
ISIN: AU000000TLX2
Telix Pharmaceuticals Ltd
TLX
LISTED
ASX
Telix to Participate in UBS and Jefferies Global Healthcare Conferences
Article
News Preview
MELBOURNE, Australia and INDIANAPOLIS, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) will participate in the upcoming UBS Global Healthcare Conference in Palm Beach, FL (U.S.) and in the Jefferies Global Healthcare Conference in London (UK)....
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
Indices
DAX, DOW, S&P, FTSE...
Realtime Trading
With & without leverage
Currencies
EUR, USD, JPY, BRL, GBP ....
50 FX-Pairs
Top Conditions, Tied spreads, Mini/Micro
Commodities
Brent, WTI, Coffee, Wheat....
Long & Short
Crude oil, Agricultural & more
Metals
Gold, Silver, Palladium, Platinum
Hedging
Soft-,Heavy-, Precious Metals
Stocks & ETF
TSLA, NFLX, NVDA, MSFT, AAPL ....
Leveraged Equity Trading
USA, Europe, Asia
More information, click here

More sector specific news

Your Press Release is missing or you want share news over GICS11? Drop us a line.

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

XLB
XLE
XLU
XLY
XLF
XLP
XLV
XLK
XLC
XLI
XLRE
© 2025 Select Sector SPDRs
* * *
More Sector related Investment Ideas
XLB
XLE
XLU
XLY
XLF
XLP
XLV
XLK
XLC
XLI
XLRE
© 2025 WEBs Investments ETFs
About the newsfeed
#1
What types of information are provided on this portal - and what purpose does it serve?
The portal provides structured, stock market-relevant company information that is specifically assigned to a particular economic sector. The focus is on current announcements from official NewsWire sources, supplemented by company profiles, filter options by sector and sector-specific research aids. The aim is to offer an interested group of people a systematically structured research environment that improves their understanding of sector developments and corporate strategies.
#2
Why are companies categorized according to a certain system?
Financial markets consist of thousands of listed companies with very different business models. In order to create transparency and comparability, companies worldwide are assigned to standardized classifications. These classifications help investors to better analyze markets, identify sector-specific trends and make more targeted investment decisions.
#3
What classification standards exist for grouping companies?
There are various industry classifications that are used depending on the region or application. The best known include GICS (Global Industry Classification Standard), ICB (Industry Classification Benchmark), NAICS (North American Industry Classification System) and TRBC (Thomson Reuters Business Classification). Most institutional investors and ETFs worldwide use GICS or ICB as a benchmark.
#4
What classification standard is this financial information portal based on?
The portal uses the Global Industry Classification Standard (GICS), which was jointly developed by MSCI and S&P Dow Jones Indices. GICS is widely used in the institutional financial world and forms the basis for many global equity indices, ETFs and research systems.
#5
What exactly does GICS mean - and how is the system structured?
GICS stands for Global Industry Classification Standard. It is a hierarchical structure that divides listed companies worldwide into four levels: Sector, Industry Group, Industry Sector and Sub-Industry. In total, the system comprises 11 main sectors, over 60 industries and more than 150 sub-categories. It allows a consistent, internationally comparable analysis of economic activities.
#6
Why is GICS important in the financial world?
GICS offers a standardized language for investment decisions. It makes it possible to compare companies with similar business models - regardless of country, stock exchange or company size. Many investment funds, indices and research houses use GICS as a basis for portfolio construction, risk analysis or market screening. This means that it also makes sense for private investors to use this structure as a guide.
#7
Who decides which GICS sector a company is assigned to?
The allocation is made by the index providers MSCI and S&P Dow Jones on the basis of a company's main business segment. The decisive factor is the segment from which the company generates the majority of its sales or operating profit. Changes in the business model or strategic realignments can lead to a company being assigned to a different industry or even a different sector.
#8
What is meant by the GICS sector "Materials"?

The GICS "Materials" sector comprises companies that are active in the production, processing or refinement of raw materials. This includes industries such as chemicals, building materials, paper & forest products and the entire metallurgical and mining industry. The sector is highly cyclical and is particularly sensitive to economic fluctuations and changes in global demand.

#9
Which companies typically belong to the Materials sector?
Typical representatives are international groups from the areas of chemicals production (e.g. BASF), precious metal mining (e.g. Barrick Gold), building materials production (e.g. Heidelberg Materials) or industrial gases (e.g. Linde). The shares of these companies are often heavily dependent on commodity prices and play a central role in industrial value chains.
#10
Where does the company news on this page come from?
The news is based on verified and publicly available sources such as BusinessWire, GlobeNewswire, PR Newswire, EQS, Newsfile, ACCESSNewswire and other NewsWire services. These platforms are used by listed companies to publish mandatory ad hoc announcements, financial reports or strategic developments. All content is prepared in a structured manner and, if a corresponding categorization is possible, brought together in industry-specific clusters.
#11
How is the sector-specific mapping of messages carried out?
Categorization is based on structured metadata (e.g. ISIN, ticker, sector classification) and a combination of keyword analysis and GICS mapping. This ensures that all news is assigned to the correct sector and - if available - the correct sub-sector.
#12
Why is the materials sector particularly interesting for investors?
The Materials sector is closely linked to global industrial production and offers both cyclical growth opportunities and hedging opportunities against inflation and raw material shortages. In addition, many companies in this sector play a key role in future topics such as electromobility, the energy transition and sustainable building materials.
#13
What distinguishes this project from traditional financial information portals?
In contrast to generic portals, this project focuses exclusively and specifically on a particular sector. The advantage for interested investors: Sector-specific information, news, market movements and company profiles can be filtered and analyzed in a more targeted manner. This enables more in-depth research and greater relevance for thematic investment decisions.
#14
Are smaller companies also represented here or only large corporations?
The newsfeed takes into account both large caps and mid and small caps. As a clear mapping criterion is required in order to enable the most precise possible allocation to a cluster, the ISIN of the listed company is generally used for this purpose, provided that this can be made available or mapped via corresponding newsfeed parameters.
#15
How up-to-date are the displayed messages?
The content is updated regularly. The publication follows the publications of the information source, the NewsWire feeds of the underlying distributors. Incoming reports are automatically processed, classified and displayed on the page. Timestamps and source information ensure maximum transparency.
#16
Can I also filter the news by sub-sector?
Yes, this is a central feature of the site. Within a main sector, you can filter specifically for sub-sectors such as "Metals & Mining". For particularly popular industries or developments within a meta-sector, it is possible to deviate from standard clusters. Special categories with particular information value enable thematic analyses to be carried out even more precisely.
#17
Are there plans to process other metasectors in a similar way?
Yes, this financial information portal is part of an extensive project in which separate information portals are being created for all the main sectors. The aim is to provide investors with a systematic, sector-based research tool - regardless of index affiliation or provider perspective.
#18
Why do companies publish announcements via NewsWire services at all?
NewsWire services such as BusinessWire or PR Newswire fulfill a regulatory function: they enable companies to publish price-sensitive information publicly and without discrimination. In many countries, the use of such services is a prerequisite for fulfilling publication obligations under capital market law. They also enable companies to reach the media, analysts and investors in a targeted manner.
#19
Can private or inactive companies also appear in such notifications?
Generally not. The platform focuses exclusively on listed companies whose disclosures are based on regulatory requirements or corporate strategy measures. Although private or unlisted companies occasionally publish announcements, these are not systematically processed or classified here.
#20
What happens when a company changes its business model - does its sector classification also change?
Yes, as a rule - but not automatically. The responsible classification institutes (e.g. MSCI and S&P for GICS) regularly check the relevance and consistency of the classifications. If there is a significant change in a company's sales or profit profile, it may be reclassified to a different industry or even a different sector. This usually takes place after fixed review cycles or upon request.
#21
How is it ensured that a company is correctly categorized if it is active in several business areas?
The categorization is based on the dominant sales segment. If a company is active in several sectors but generates 70% of its turnover with chemical products, for example, it is assigned to the GICS sector "Materials" - even if it also has activities in the energy or transportation sector. In borderline cases, additional qualitative assessment criteria apply.
#22
Are there any legal risks in the further use of the displayed content?
The content comes from public sources, but is partially subject to copyright protection - particularly with regard to text structure and layout. The excerpts and links provided on this portal are made within the scope of permitted use (e.g. right to quote or editorial processing). However, commercial use by third parties is not permitted without the express permission of the original providers.
#23
Who can I contact if I have general questions or legal concerns?
A central contact point is available for general inquiries, information on company recordings, compliance issues or copyright-relevant aspects. In rare cases, for example in the case of erroneously published information or justified requests for deletion, a review and, if necessary, removal from the public feed can take place. Please only use the official contact option in the legal notice or at the bottom of the page.
#24
Is advertising or third-party content also displayed on the portal?
Yes, in defined areas the portal can display advertising content or product-specific information from third parties - for example on sector-related financial services, research offers or trading platforms. This content is clearly marked as advertising or partner information and is separate from the editorial or automatically processed company news.
#26
Can I give feedback on the platform or submit suggestions?
Absolutely - feedback is expressly welcome. The platform is an open information service that is continuously being developed. Comments on functionality, data quality, usability or thematic extensions help to optimize the service for the benefit of users. You can submit your suggestions informally via the contact page or special feedback forms.
#27
I am an information provider - can I cooperate with the portal?
Yes, the portal is open to content-related, technical or editorial cooperation, provided that this contributes to the quality, relevance or dissemination of the offering. If you offer content, interfaces or services that could be useful in the context of stock market-related information, we would be pleased to hear from you. The platform offers flexible integration options and a professional environment for quality-assured content.
#28
Can the platform technology also be used for other applications or partners?
Yes, the platform is based on a modular, scalable infrastructure that can be adapted to different information contexts and industry models. Technical components such as data aggregation, structuring logic, classification mechanisms and semantic filters can also be made available for external projects or individual applications on request. Please contact us for cooperation or license models.
#29
Can the underlying company data also be licensed or reused?
Structured access to selected master data of listed companies - such as GICS mapping, ISIN mapping, news feeds or metadata filters - is generally possible. The offer is aimed in particular at information service providers, research platforms or data-driven financial applications. Data can be provided via defined interfaces (e.g. API) or exportable formats, depending on the intended use and license framework.
#30
What forms of cooperation with external partners are conceivable?
Basically open. Possible forms of cooperation range from technical integrations and shared data models to content syndication or white label solutions. Partnerships with institutions that are looking for access to quality-assured data, dynamically structured news or sector-specific analyses - for example in the FinTech, media or research environment - are particularly interesting. We look forward to hearing from business development or product management departments.
#31
Why does this portal differ technically and conceptually from other information offerings?
Because no one from outside the industry is trying to understand the financial market here - but because the know-how comes from the heart of the financial world. The technical platform was developed by a team that combines in-depth market knowledge with innovative system design. The result: information architecture with real relevance, not shop window technology.
#32
What makes the technical solution particularly interesting for operators of their own financial portals?
In addition to high adaptability, the platform impresses with its modular structure and the consistent implementation of industry-specific logic - from GICS mapping to metadata filtering. For providers who operate their own information portals, sector-specific data structures, news feeds or visualizations can be quickly integrated on this basis - either as a white label, API module or embedded solution.
#33
Why can a collaboration go beyond traditional development services?
Because we don't just program, we think: The technological implementation is based on a deep understanding of market cycles, regulations, data formats and investor needs. Anyone who cooperates with this platform benefits from a sparring partner at eye level - both technically and professionally. This creates added value that goes far beyond pure IT expertise.
#34
Note on copyright and the processing of original content
The corporate news presented on this information portal is based on publicly accessible sources such as BusinessWire, GlobeNewswire, PR Newswire or comparable news services. The content is processed as part of an automated or editorially supported structuring process without changing, shortening or reinterpreting the content of the original information. This is so-called "as is" information, the form and content of which corresponds to the originally published announcement. The rights to the original texts remain unrestrictedly with the respective publishers or copyright holders. This portal merely assumes a structural categorization and allocation within the framework of a news-journalistic offer. Independent commercial reuse, systematic reproduction or other use of the content by third parties is only permitted within the framework of the statutory provisions or with the consent of the copyright holder.
About GICS Health
GICS Health is part of the GICS Eleven information portfolio, which focuses primarily on information from listed companies in the health sector. The sector classification serves as a guide to navigate quickly and conveniently through the latest industry-specific news. Individual peer group clusters complement the news offering.
About GICS Eleven

GICS Eleven (G11, GICS11) bundles topic-specific content and enables quick access to relevant information thanks to its gate function. The project is largely based on the Global Industry Classification Standard (GICS®), which was developed by MSCI and Standard & Poor's and enables a breakdown into sectors. GICS® consists of 11 sectors, 24 industry branches, 69 industries and 158 sub-industries.

GICS® is a registered trademark of MSCI Inc. and S&P Dow Jones Indices.

Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Wednesday, 05.11.2025, Calendar Week 45, 309th day of the year, 56 days remaining until EoY.